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ABSTRACT
Background and Objectives: Laparoscopic gastrojeju-
nostomy (LGJ) has been proposed as the technique pre-
ferred over open gastrojejunostomy for relieving gastric
outlet obstruction (GOO) due to malignant and benign
disease. This study investigates the feasibility and safety of
LGJ for GOO.
Methods: A retrospective review was performed of pa-
tients who underwent LGJ at Mount Sinai Medical Center
from 2004 to 2008. Patient’s operative course and long-
term outcomes were collected.
Results: Twenty-eight patients were reviewed (16 had
malignancy, 7 had PUD, 3 had Crohn’s disease, and one
had obstruction of unclear cause). Average operative time
was 170 minutes, and estimated blood loss was 80cc. One
case was converted to open; another had stapler misfiring.
Patients regained bowel function at a median of 3 days
and remained in the hospital for a median of 8 days. There
were 4 major postoperative complications (14%): 1 anas-
tomotic leak and 1 trocar-site hemorrhage requiring reop-
eration and 2 gastrointestinal bleeds requiring endoscopic
intervention. There were 5 minor complications (18%),
including a partial small bowel obstruction, 1 patient de-
veloped bacteremia, and 3 patients had delayed gastric
emptying. One patient had persistent GOO requiring re-
operation 3 months later.
Conclusion: LGJ can be performed for GOO with im-
proved outcome and an acceptable complication rate
compared to the open GJ reported in the literature.
Key Words: Gastrojejunostomy, Laparoscopic gastrojeju-
nostomy, Gastric outlet obstruction, Peptic ulcer disease.
INTRODUCTION
Gastric outlet obstruction (GOO) can be a consequence of
advanced stages of several disease processes. Historically,
peptic ulcer disease (PUD) was the primary and most
common cause of GOO.1–3 In the modern era of proton-
pump inhibitors and eradication of H. pylori, GOO from
PUD is a rare occurrence, and most are now due to
periampullary malignancies.4,5 The aim of surgery, espe-
cially for patients with advanced malignancies, is to re-
establish oral intake and stabilize and improve quality of
life.6–8Different modalities have been described for treat-
ing GOO. Open gastrojejunostomy (GJ) has been the
traditional surgical approach.9–11 However, patients with
an open laparotomy, compared to laparoscopic surgery,
tend to experience more pain and stay for a longer post-
operative course in the hospital. With the prevalence of
minimally invasive surgery, laparoscopic GJ has been pro-
posed as a preferred technique to minimize patient mor-
bidity and mortality.10,12
There is a paucity of data on the operative details and
postoperative course of patients with laparoscopic gastro-
jejunostomy. This study aimed to investigate the feasibility
and safety of laparoscopic gastrojejunostomy in relieving
GOO in patients with malignant and benign disease.
METHODS
A retrospective review of patients who underwent lapa-
roscopic gastrojejunostomy at Mount Sinai Medical Cen-
ter, New York, New York, from 2004 to 2008 was per-
formed. Cases were identified through the use of a
hospital database. Records were reviewed with respect to
patient demographics and outcomes, medical history, pre-
senting symptoms, diagnostic workup, operative details,
postoperative course, and pathologic characteristics.
Long-term outcome and survival were determined by us-
ing the Social Security Death Index and hospital records.
Institutional review board approval was obtained for this
study.
Operative Technique
In this study, the abdomen was entered using either Ver-
ess needle insufflations or the Hasson technique. In gen-
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SCIENTIFIC PAPEReral, between 4 to 5 trocars were placed in the upper
abdomen under direct vision, with 1 to 2 of these trocars
being 12mm in size and the rest being 5mm. After place-
ment of trocars, the greater curvature of the stomach was
identified. The majority of the surgeries were antecolic GJ,
given the increased risk for internal hernia with retrocolic
GJ. The gastrocolic omentum was opened using an ultra-
sonic or Harmonic scalpel. The lesser sac was entered,
and the distal stomach was identified. The position on the
distal stomach for creation of the GJ was based on sur-
geon’s preference. A loop of small bowel approximately
30cm to 50cm distal to the ligament of Treitz was chosen
for the gastrojejunostomy. A laparoscopic stay suture was
used to align the small bowel segment in an antecolic
manner to the anterior or posterior wall of the stomach.
Enterotomies were then made with cautery in both the
jejunum and stomach. Two to 3 staplers were used to
create the anastomosis. The common enterotomy was
closed laparoscopically with 2 layers of sutures. A subse-
quent esophagogastroduodenoscopy and air leak test
were performed in every case.
Complications
The complication rate was classified as 30-day postoper-
ative complications, and separated into major and minor
complications. A major complication was defined as any
postoperative complications that were life threatening or
required endoscopic or surgical intervention. Minor com-
plications were those that were moderately severe but not
life-threatening, such as infection, fever, or delayed gastric
emptying (defined as the inability to tolerate liquid PO 7
days after surgery). These parameters were similar to ones
used in prior studies on laparoscopic GJ.13 In addition, the
30-day mortality rate was recorded.
RESULTS
Demographics
A total of 28 patients were reviewed. Average age was 68
(range, 25 to 99), and 64% were female. A CT was ob-
tained in most of these cases, and sometimes an upper
endoscopy was performed to make the diagnosis of gas-
tric outlet obstruction.
Sixteen patients had malignancy as their cause of GOO, 7
patients had peptic ulcer disease, 3 patients had Crohn’s
Disease, and 1 patient had an obstruction of unknown
cause (Table 1). While all patients had symptoms of
gastric outlet obstruction, 13 (46%) had gastrointestinal
bleeding or were guaiac positive at the time of admission.
Comorbidities were common with hypertension, coronary
artery disease, diabetes, COPD, and HIV present in 67%,
33%, 15%, 11%, and 4%, respectively. Forty-four percent
of patients with malignancy were immunosuppressed
from chemotherapy, and 66% of Crohn’s patients were on
steroids at the time of surgery. Overall, 36% of patients
were of poor nutritional status (albumin3.0) periopera-
tively, with an average albumin level of 3.4 (Table 2).
Two patients were on preoperative TPN. One patient with
metastatic colon cancer had been on TPN for 2 months
prior to surgery, and postoperatively was discharged
home tolerating a diet without TPN. The second patient
had gastric cancer and had been on TPN preoperatively
for 1 month; she was discharged home tolerating a diet
without TPN. Twenty-four of the cases (86%) were elec-
tive, while 4 were gastric outlet obstructions requiring
emergent surgery. For the elective cases, the duration of
obstruction ranged from 1 week to 6 months.
Surgical Outcomes
The average operative time was 170 minutes, with an
average estimated blood loss of 80cc. Average ASA score
was 3. There was no significant difference in outcomes
due to surgeon’s operative experience. Only one case was
converted to open GJ after extensive adhesions were
encountered, resulting in enterotomies. Another case had
stapler misfire, which required an additional 2-layered
suturing reinforcement of the anastomosis. Intraoperative
esophagogastroduodenoscopy for this patient confirmed
patent anastomosis without leak.
Table 1.






Crohn’s Disease 3 11%






Small bowel cancer 3
Gallbladder cancer 2
Neuroendocrine 1
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their bowel function was 3 days. They were placed on a
clear diet by day 3 and on a regular diet by day 5. The
median postoperative length of stay was 8 days (range 2 to
83) (Table 3).
A total of 9 early postoperative complications occurred,
requiring 2 reoperations and 2 endoscopic interventions.
Two patients had bleeding from the gastrojejunostomy
site on postoperative day 2 and 7. One was an arterial
bleed at the gastric side of the anastomosis on postoper-
ative day 2 that was controlled by epinephrine injection.
The second patient had metastatic cholangiocarcinoma
and PUD and was found to have a bleeding duodenal
ulcer and small ulcer near the GJ anastomosis. Both of
these areas were injected with epinephrine and electro-
cauterized.
Two of the 28 patients (7%) required reoperations. One
patient had an anastomotic leak requiring open repair of
GJ on postoperative day 5. This patient had an arduous
postoperative course complicated by septic shock, respi-
ratory failure necessitating a tracheostomy, and formation
of an enterocutaneous fistula that was repaired 3 weeks
later. She ultimately improved and was discharged to
subacute rehabilitation 10 weeks after her initial surgery.
The second patient had trocar site hemorrhage on post-
operative day 3 and was taken back to the operating
room.
The patient with the intraoperative misfiring of the stapler
tolerated a regular diet initially, but then vomited on
postoperative day 10 and developed a partial small bowel
obstruction. The cause of this obstruction was unclear, but
the symptoms resolved with 3 days of nasogastric tube
decompression. This patient was discharged home on
postoperative day 14 tolerating a regular diet.
The 5 patients described above had delayed gastric emp-
tying due to their complications. In addition, 4 more
patients had delayed oral intake postoperatively (7
days). These 4 patients had prolonged postoperative ileus
and were eventually able to tolerate a regular diet on
postoperative day 8, 9, 11, and 28 (Table 4).
There was one long-term failure of GJ. A patient with
cholangiocarcinoma was discharged home tolerating a GI
soft diet, but returned 3 months later with persistent GOO.
He required an open jejunostomy tube and a gastrostomy
tube for decompression.
DISCUSSION
Different modalities have been described for the treatment
of GOO from advanced malignancy and benign disease.
Open GJ used to be the only method to relieve GOO.































Operation duration (average) (min) 170
ASA Score (average) 3
Estimate Blood Loss (average) (cc) 80
Conversion to open 1




Length of stay (median, in days) 8
Regain of bowel function (median, in days)
Liquid PO 3
Flatus or BM 3
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commonly being used. In this study, we reviewed our
institution’s experience of laparoscopic gastrojejunostomy
as a treatment modality for GOO.
The operative time for laparoscopic GJ was on average
170 minutes, which was slightly longer than time for an
open GJ procedure reported in literature (average, 115
minutes).14–16 This was to be expected, because laparo-
scopic GJ is technically more difficult than open surgery.
This operative time was also likely surgeon- and patient-
dependent. Prior studies16 have shown that operative time
decreases as individual surgeons become more experi-
enced. In addition, patients who were obese, had prior
surgeries, or had significant disease burden in the area
would require a longer time for dissection. As anticipated,
the estimated blood loss was nominal for laparoscopic GJ
(average, 80cc), and considerably less than that with open
procedures. Previous studies12,15,17 had shown that open
GJ could have an estimated blood loss of between 140cc
to 270cc.
The median length of postoperative hospital stay found in
this study was 8 days, which is shorter than the reported
length of stay for open cases. Jeurnink et al13 performed a
systemic review of published series on GJ between 1996
and 2006. Of the 297 cases of GJ, 226 patients had open
GJ, and their average length of stay ranged from 8.5 days
to 24 days. Patients in this study had a median time to
solid food intake of 5 days, which was comparable to that
of laparoscopic GJ cases cited in the literature. Alam et al18
and Kazanjian et al19 both reviewed patients with GOO
secondary to inoperable cancer and found the median
time to solid food after laparoscopic GJ to be 4 days. In
contrast, open GJ generally required 7 days before a
patient could resume solid food.15 These data show that
laparoscopic GJ can achieve excellent results with re-
duced intraoperative blood loss, earlier recovery of oral
feeding, and shorter length of stay than open GJ can. For
patients with malignancy as their underlying cause of
GOO, laparoscopic gastrojejunostomy, as expected, did
not improve their overall survival. The lifespan for these
patients ranged from 3 months to 11⁄2 years after laparo-
scopic GJ. However, laparoscopic GJ did allow for earlier
recovery and shorter length of stay in the hospital. In
addition, open surgery always carries the risk of develop-
ment of an incisional hernia postoperatively. In this study,
none of the patients had a documented incisional hernia
that required repair on follow-up.
In a group of 28 laparoscopic GJ, the major complication
rate was 14%, which is comparable to the complication
rate in prior laparoscopic GJ studies, and comparable to, if
not better than, that of open GJ. In the Jeurnink et al13
systemic review of open and laparoscopic GJ, major com-
plication was defined in similar terms as those used in our
study. They found a major complication rate of 0% to 31%
after laparoscopic GJ, and 0% to 88% after open GJ. In this
study, the most common complication was delayed gastric
emptying. Guzman et al12 also found delayed gastric emp-
tying as the most common complication in 4 of their 20
patients (20%) after laparoscopic GJ. Brune et al20 also had
similar results, with delayed gastric emptying in 3 of 16
patients (18%).
Our study has several limitations. This was a review of our
institution’s experience with laparoscopic GJ for GOO,
and these results may not apply to other institutions.
However, our results were similar to results of prior stud-
ies on laparoscopic GJ that suggest that laparoscopic GJ
has better outcomes than open GJ has. A second study
will be needed to compare laparoscopic GJ to case-con-
trolled open GJ cases. This will allow for a direct compar-
ison of the perioperative variable and outcome of open
versus laparoscopic GJ for patients with similar underlying
causes of GOO and comorbidities. In addition, further
study should examine the efficacy and feasibility of lapa-
roscopic GJ in patients with different underlying disease
processes.
CONCLUSION
Laparoscopic GJ has become more recognized as an ac-
ceptable alternative to open GJ for the treatment of GOO.











Trocar site bleed 1
Anastomotic leak 1
UGI bleed 2
Minor complications 5 18%
Low grade SBO 1
Delayed gastric emptying (7 days) 4
Long-term Complications
Dysfunction of GJ 1 4%
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disease. Patients in this study had reduced intraoperative
blood loss, earlier recovery of oral feeding, and shorter
length of stay than patients who underwent open GJ.
Laparoscopy was safe and carried a comparable, if not
lower, morbidity and perioperative mortality compared to
that reported in open GJ studies.
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